Blog
Cannabis
A Rescheduling Q&A with Alisha Holloway
A Q&A with Phylos’ Chief Scientific Officer, Dr. Alisha Holloway, PhD, discussing the impact of rescheduling cannabis to Schedule III to researchers. The recent announcement from the US Department of Justice confirms something people have known for millennia: cannabis has undeniable therapeutic benefits. Rescheduling to Schedule III is a major step forward towards more research into cannabinoid safety and efficacy, allowing us to better understand the plant’s medicinal value through a modern and scientific lens.
Read MoreF1 Hybrid Seeds–A proven game changer for cannabis cultivation
Choosing the best genetics for your cannabis grow – whether it is for your backyard or a 100,000 sq ft facility – is pivotal for your success. Historically for cannabis cultivation, clones have been the only way to grow uniform, high potency plants. Phylos applies modern breeding techniques to elite genetics to give growers access to F1 Hybrid seeds that produce plants with all the best traits of clonal cultivars at a significantly lower operating cost.
Read MoreBelieve it: these seeds will outperform your clones
Director of Business Development, Ben Adams, thinks Elite Seeds will fundamentally change cultivation practices. Phylos Elite F1 Hybrid Seeds have incredible vigor & uniformity, 25-30%+ THC, are HLVD-free and fully feminized with up to 98%+ germination rates.
Read MoreThe Value of Change
This case study examines a trial conducted by a US-based and licensed commercial cannabis cultivator that wanted to measure the productivity of seed-based cultivation and estimated production costs compared to clonal-based propagation.
Read MoreWebinar: Scale and increase profitability with uniform seed-grown production
Phylos’ latest webinar, “Scale and Increase Profitability with Uniform Seed-Grown Production” hosted by MJ Biz Daily features industry leaders in breeding & cultivation as they discuss the many reasons why seeds are the future of cannabis production.
Read MoreUnderstanding the (major) potential of minor cannabinoids
Since 1964, delta-9-THC, remains the most discussed & demanded cannabinoid in the marketplace. As cannabis research continues to grow at an exponential rate, scientists have identified & isolated other cannabinoids that are now considered mainstream.
Read MoreModern seed-grown cannabis makes sense - but does it make cents?
The field of cannabis seed genetics has made resounding advances in the past decade. With these advances, many preconceived notions, myths, and misconceptions about seed-grown cannabis have been dispelled, leaving them as relics of the past.
Read MoreWhy seed-grown cannabis is the new move for commercial growers
Advances in breeding innovation has brought a new option to growers focused on uniformity, input reduction, and risk mitigation: Phylos Production-Ready™ Seed
Read MoreHow autoflower can save a short season
With the rapid expansion of the cannabis and hemp industries, growers have quickly learned that these crops are just as vulnerable to the threat of a short season as others. Learn how autoflower and other short-season varieties can save a short season.
Read More